Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 12/2012

01-12-2012 | Article

CURB-65 score predicted mortality in community-acquired pneumonia better than IDSA/ATS minor criteria in a low-mortality-rate setting

Authors: Q. Guo, H.-Y. Li, Y.-P. Zhou, M. Li, X.-K. Chen, H. Liu, H.-L. Peng, H.-Q. Yu, X. Chen, N. Liu, L.-H. Liang, Q.-Z. Zhao, M. Jiang

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 12/2012

Login to get access

Abstract

The CURB-65 scoring system performs well at identifying patients with pneumonia who have a low risk of death. Whether it predicts mortality in community-acquired pneumonia (CAP) better than the 2007 Infectious Disease Society of America (IDSA)/American Thoracic Society (ATS) minor criteria in low-mortality-rate settings is not clear. The purpose of this study was to determine the hypothesis.A total of 1,230 adult inpatients admitted to our hospital from 2005 to 2009 for CAP were reviewed retrospectively.The hospital mortality was 1.3 %. Percentage mortality increased significantly with CURB-65 score and the increasing number of IDSA/ATS minor criteria present. The number of CURB-65 criteria or IDSA/ATS minor criteria present had significant increased odds ratios for mortality of 7.547 and 2.711, respectively. The sensitivities of a CURB-65 score of ≥3 and the presence of ≥3 minor criteria in predicting mortality was 25 % and 37.5 %, which increased to 75 % and 62.5 %, while the cut-off values reduced to ≥2 criteria, respectively. The area under the receiver operating characteristic curve for CURB-65 was greater than the corresponding area for IDSA/ATS minor criteria in predicting hospital mortality (0.915 vs. 0.805, p = 0.0091).CURB-65 score predicted hospital mortality better than IDSA/ATS minor criteria, and a CURB-65 score of ≥2 or the presence of ≥2 minor criteria might be more valuable cut-off values for “severe” CAP in a low-mortality-rate setting.
Literature
1.
go back to reference Mandell LA, Wunderink RG, Anzueto A et al (2007) Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 44(Suppl 2):S27–S72PubMedCrossRef Mandell LA, Wunderink RG, Anzueto A et al (2007) Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 44(Suppl 2):S27–S72PubMedCrossRef
2.
go back to reference Guo Q, Li YM, Nong LB et al (2009) Evaluation of compliance with bundle treatment in the management of severe infection. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 21:8–12PubMed Guo Q, Li YM, Nong LB et al (2009) Evaluation of compliance with bundle treatment in the management of severe infection. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 21:8–12PubMed
3.
go back to reference Restrepo MI, Anzueto A (2009) Severe community-acquired pneumonia. Infect Dis Clin North Am 23:503–520PubMedCrossRef Restrepo MI, Anzueto A (2009) Severe community-acquired pneumonia. Infect Dis Clin North Am 23:503–520PubMedCrossRef
4.
go back to reference British Thoracic Society Standards of Care Committee (2001) BTS guidelines for the management of community acquired pneumonia in adults. Thorax 56(Suppl 4):IV1–IV64 British Thoracic Society Standards of Care Committee (2001) BTS guidelines for the management of community acquired pneumonia in adults. Thorax 56(Suppl 4):IV1–IV64
5.
go back to reference Lim WS, Baudouin SV, George RC et al (2009) BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 64(Suppl 3):iii1–iii55PubMedCrossRef Lim WS, Baudouin SV, George RC et al (2009) BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 64(Suppl 3):iii1–iii55PubMedCrossRef
6.
go back to reference Guo Q, Li HY, Zhou YP et al (2011) Weight of the IDSA/ATS minor criteria for severe community-acquired pneumonia. Respir Med 105:1543–1549PubMedCrossRef Guo Q, Li HY, Zhou YP et al (2011) Weight of the IDSA/ATS minor criteria for severe community-acquired pneumonia. Respir Med 105:1543–1549PubMedCrossRef
7.
go back to reference Liapikou A, Ferrer M, Polverino E et al (2009) Severe community-acquired pneumonia: validation of the Infectious Diseases Society of America/American Thoracic Society guidelines to predict an intensive care unit admission. Clin Infect Dis 48:377–385PubMedCrossRef Liapikou A, Ferrer M, Polverino E et al (2009) Severe community-acquired pneumonia: validation of the Infectious Diseases Society of America/American Thoracic Society guidelines to predict an intensive care unit admission. Clin Infect Dis 48:377–385PubMedCrossRef
8.
go back to reference Loke YK, Kwok CS, Niruban A et al (2010) Value of severity scales in predicting mortality from community-acquired pneumonia: systematic review and meta-analysis. Thorax 65:884–890PubMedCrossRef Loke YK, Kwok CS, Niruban A et al (2010) Value of severity scales in predicting mortality from community-acquired pneumonia: systematic review and meta-analysis. Thorax 65:884–890PubMedCrossRef
9.
go back to reference Falcone M, Corrao S, Venditti M et al (2011) Performance of PSI, CURB-65, and SCAP scores in predicting the outcome of patients with community-acquired and healthcare-associated pneumonia. Intern Emerg Med 6:431–436PubMedCrossRef Falcone M, Corrao S, Venditti M et al (2011) Performance of PSI, CURB-65, and SCAP scores in predicting the outcome of patients with community-acquired and healthcare-associated pneumonia. Intern Emerg Med 6:431–436PubMedCrossRef
10.
go back to reference Jones BE, Jones J, Bewick T et al (2011) CURB-65 pneumonia severity assessment adapted for electronic decision support. Chest 140:156–163PubMedCrossRef Jones BE, Jones J, Bewick T et al (2011) CURB-65 pneumonia severity assessment adapted for electronic decision support. Chest 140:156–163PubMedCrossRef
11.
go back to reference Phua J, See KC, Chan YH et al (2009) Validation and clinical implications of the IDSA/ATS minor criteria for severe community-acquired pneumonia. Thorax 64:598–603PubMedCrossRef Phua J, See KC, Chan YH et al (2009) Validation and clinical implications of the IDSA/ATS minor criteria for severe community-acquired pneumonia. Thorax 64:598–603PubMedCrossRef
12.
go back to reference Hilbert G, Gruson D, Vargas F et al (2001) Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure. N Engl J Med 344:481–487PubMedCrossRef Hilbert G, Gruson D, Vargas F et al (2001) Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure. N Engl J Med 344:481–487PubMedCrossRef
13.
go back to reference Niederman MS, Mandell LA, Anzueto A et al (2001) Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 163:1730–1754PubMed Niederman MS, Mandell LA, Anzueto A et al (2001) Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 163:1730–1754PubMed
14.
go back to reference Dellinger RP, Carlet JM, Masur H et al (2004) Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 32:858–873PubMedCrossRef Dellinger RP, Carlet JM, Masur H et al (2004) Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 32:858–873PubMedCrossRef
15.
go back to reference Aujesky D, Auble TE, Yealy DM et al (2005) Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia. Am J Med 118:384–392PubMedCrossRef Aujesky D, Auble TE, Yealy DM et al (2005) Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia. Am J Med 118:384–392PubMedCrossRef
16.
go back to reference Brown SM, Jones BE, Jephson AR et al (2009) Validation of the Infectious Disease Society of America/American Thoracic Society 2007 guidelines for severe community-acquired pneumonia. Crit Care Med 37:3010–3016PubMedCrossRef Brown SM, Jones BE, Jephson AR et al (2009) Validation of the Infectious Disease Society of America/American Thoracic Society 2007 guidelines for severe community-acquired pneumonia. Crit Care Med 37:3010–3016PubMedCrossRef
17.
go back to reference Schuetz P, Koller M, Christ-Crain M et al (2008) Predicting mortality with pneumonia severity scores: importance of model recalibration to local settings. Epidemiol Infect 136:1628–1637PubMedCrossRef Schuetz P, Koller M, Christ-Crain M et al (2008) Predicting mortality with pneumonia severity scores: importance of model recalibration to local settings. Epidemiol Infect 136:1628–1637PubMedCrossRef
18.
go back to reference Lim WS, van der Eerden MM, Laing R et al (2003) Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 58:377–382PubMedCrossRef Lim WS, van der Eerden MM, Laing R et al (2003) Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 58:377–382PubMedCrossRef
19.
go back to reference Niederman MS, McCombs JS, Unger AN et al (1998) The cost of treating community-acquired pneumonia. Clin Ther 20:820–837PubMedCrossRef Niederman MS, McCombs JS, Unger AN et al (1998) The cost of treating community-acquired pneumonia. Clin Ther 20:820–837PubMedCrossRef
20.
go back to reference Colice GL, Morley MA, Asche C et al (2004) Treatment costs of community-acquired pneumonia in an employed population. Chest 125:2140–2145PubMedCrossRef Colice GL, Morley MA, Asche C et al (2004) Treatment costs of community-acquired pneumonia in an employed population. Chest 125:2140–2145PubMedCrossRef
21.
go back to reference Bartolomé M, Almirall J, Morera J et al (2004) A population-based study of the costs of care for community-acquired pneumonia. Eur Respir J 23:610–616PubMedCrossRef Bartolomé M, Almirall J, Morera J et al (2004) A population-based study of the costs of care for community-acquired pneumonia. Eur Respir J 23:610–616PubMedCrossRef
Metadata
Title
CURB-65 score predicted mortality in community-acquired pneumonia better than IDSA/ATS minor criteria in a low-mortality-rate setting
Authors
Q. Guo
H.-Y. Li
Y.-P. Zhou
M. Li
X.-K. Chen
H. Liu
H.-L. Peng
H.-Q. Yu
X. Chen
N. Liu
L.-H. Liang
Q.-Z. Zhao
M. Jiang
Publication date
01-12-2012
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 12/2012
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-012-1693-8

Other articles of this Issue 12/2012

European Journal of Clinical Microbiology & Infectious Diseases 12/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine